The largest database of trusted experimental protocols

Glyceraldehyde 3 phosphate dehydrogenase gapdh sc 365062

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (sc-365062) is a protein that catalyzes the sixth step of glycolysis, the conversion of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate. It is a critical enzyme in the breakdown of glucose to generate energy in the form of ATP.

Automatically generated - may contain errors

2 protocols using glyceraldehyde 3 phosphate dehydrogenase gapdh sc 365062

1

Prostate Cancer Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
LNCaP and 22Rv1 cells were obtained from the American Type Culture Collection in 2012 (ATCC). C4‐2 cells were obtained from MD Anderson Cancer Center Cell Line Core Facility in 2016 (Houston, TX). All cells were maintained in Rosewell Park Memorial Institute supplemented with 10% fetal bovine serum. Cell line authentication was performed using short tandem repeat profiling (GenePrint 10 kit, Promega). Mycoplasma detection is performed on a plate luminometer using a mycoplasma enzyme‐based luciferase assay (MycoAlert PLUS Mycoplasma Detection Kit, Lonza). Low‐passage (<15) cultures were used for all experimental testing, Enzalutamide (MDV3100), venetoclax (ABT‐199), navitoclax (ABT‐263), A‐1210477, obatoclax, MK2206, and buparlisib were purchased from Selleck Chemicals. Antibodies for Western blot analysis include glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) (sc‐365062) and tubulin (sc‐8035): Santa Cruz Biotechnologies; NOXA (114C307): Novus Biologicals; PARP‐1 cleaved (5625), BCL‐2 (4223), BCL‐xL (2764), MCL‐1 (5433), BAX (5023), BIM 2933), BAD (9239), pBAD‐Ser136 (4366), Akt (4691), and pAkt‐Ser473 (4060): Cell Signaling Technology.
+ Open protocol
+ Expand
2

Western Blot Analysis of Cell Lysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monolayer cells and spheroids were washed with phosphate-buffered saline and lysed in 150 µL of RIPA buffer (50 mM Tris-HCl (pH 7.9), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS)). After freezing the lysate at −80°C, the protein concentration was determined by the BCA assay (Nacalai), and was adjusted with the RIPA buffer followed by mixing with 2× Laemmli sample buffer (10% β-mercaptoethanol, 125 mM Tris-HCl (pH 6.8), 4% SDS, 20% glycerol, 0.004% bromophenol blue). The samples were subjected to SDS-polyacrylamide gel electrophoresis. Following transfer to the PVDF membranes, immunoblotting was performed. Antibodies against CD44 (#3570; Cell Signaling Technology, Danvers, MA, USA), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (sc-365062; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and p21CDKN1A (sc-397-G; Santa Cruz Biotechnology) were used.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!